site:www.pharmtech.com - 搜索图片

1280×720
www.pharmtech.com
GSK, Cambridge to Partner on R&D for Kidney and Respiratory Diseases
1280×720
www.pharmtech.com
Phase III Results Show Balfaxar Non-Inferior to Kcentra in Reversing ...
1280×720
www.pharmtech.com
Phase III Results Show Balfaxar Non-Inferior to Kcentra in Reversing ...

1280×720
www.pharmtech.com
AstraZeneca Poised to Acquire Cell Therapy Developer, Gracell, in Deal ...
1280×720
www.pharmtech.com
Advent International, Warburg Pincus Complete $4.25 Billion Acquisition ...
1280×720
www.pharmtech.com
Advent International, Warburg Pincus Complete $4.25 Billion Acquisition ...

1631×833
www.pharmtech.com
Optimizing Drug Delivery Methods With Nanotechnologies
1280×720
www.pharmtech.com
Frequently Asked Questions about Batch Records
3840×2556
www.pharmtech.com
Frequently Asked Questions about Batch Records
1280×1049
www.pharmtech.com
Improvements to EMA’s PRIME Designation Scheme

3840×3014
www.pharmtech.com
Improvements to EMA’s PRIME Designation Scheme
1280×720
www.pharmtech.com
Improvements to EMA’s PRIME Designation Scheme
1280×720
www.pharmtech.com
3D Printing Medicines with FABRX at CPHI Barcelona
1280×720
www.pharmtech.com
CDER Approved 55 Novel Drugs in 2023

3336×2502
www.pharmtech.com
The EU AI Act
3024×4032
www.pharmtech.com
EMA Overhauls the Medicine L…
2357×3150
www.pharmtech.com
EMA Overhauls the Medicine L…
1200×2134
www.pharmtech.com
Diversifying the Supply of Ra…
800×1067
www.pharmtech.com
QRM, Knowledge Ma…
1280×720
www.pharmtech.com
Pelletization: Revolutionizing Drug Formulation and Delivery

1280×720
www.pharmtech.com
Pelletization: Revolutionizing Drug Formulation and Delivery

某些结果已被隐藏，因为你可能无法访问这些结果。显示无法访问的结果